Women undergoing colposcopy. Cervical high risk human papillomavirus (HPV) DNA test positive
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Definite confirmation of Human Papilloma Virus (HPV) , 2.willingness to participate in the study, 3.having minimal reading and writing skills.
Exclusion criteria
Exclusion criteria: 1. Participant's unwillingness to continue cooperation during each stage of the study, 2. History of seizures and epilepsy, dizziness and active vomiting, 3. Absence of vision and hearing disorders, 4. Absence of chronic diseases before or during treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of anxiety and pain caused by colposcopy. Timepoint: Measuring anxiety caused by colposcopy before colposcopy and measuring anxiety caused by colposcopy and pain intensity after colposcopy. Method of measurement: Spielberger manifest anxiety scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Oroumia University of Medical Sciences